Review



stempeucel  (Stempeutics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Stempeutics stempeucel
    Stempeucel, supplied by Stempeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stempeucel/pmc13176351-22-2-3
    Average 86 stars, based on 1 article reviews
    stempeucel - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Rebuilding the myocardial microenvironment to enhance mesenchymal stem cells-mediated regeneration in ischemic heart disease
    Article Snippet: One is Stempeucel for atherosclerotic and non-atherosclerotic critical limb ischemia, developed by Stempeutics; and the other is Vescell (ACP-01), under development by Hemostemix, for the treatment of IHD.

    Article Title: Stem cell therapies in the clinic
    Article Snippet: [Stempeucel®]; Stempeutics , Bone marrow , Allogeneic , Critical limb ischemia due to Buerger's disease, knee osteoarthritis , 2017 (DCGI) , No , Intralesional/Intramuscular , 2 , .

    Article Title: Stem cell therapies in the clinic
    Article Snippet: Products such as Queencell® (Anterogen), Cellgram® (Pharmicell), Cupistem® (Anterogen), Stempeucel® (Stempeutics), and Alofisel® (TiGenix NV/Takeda) are all approved for soft tissue indications.

    Article Title: Enabling Mesenchymal Stromal Cells and Their Extracellular Vesicles Clinical Availability—A Technological and Economical Evaluation
    Article Snippet: Stempeucel/2016 Stempeutics R. , Buerger's disease , 1 − 2 × 10 6 cells/kg (Ramezankhani et al. ) , ∼1980 (Ramezankhani et al. ) .

    Article Title: Clinical translational research on stem cell products: prospects and challenges
    Article Snippet: BM-MSCs , Stempeucel (Stempeutics Research) , Severe limb ischemia , India , 2016,2020.

    Article Title: Clinical experience with cryopreserved mesenchymal stem cells for cardiovascular applications: A systematic review
    Article Snippet: Currently, several MSC-based products are available on the market, including Prochymal (Osiris Therapeutics, Canada), Cartistem (Medipost Co Ltd, Korea), and Stempeucel (Stempeutics Research), Cellgram-AMI (FCB Pharmicell, South Korea) (Alliance for Regenerative Medicine; https://alliancerm.org/available-products/ ), but their functionality and clinical efficacy are still under scrutiny.

    Article Title: The inconclusive superiority debate of allogeneic versus autologous MSCs in treating patients with HFrEF: a systematic review and meta-analysis of RCTs.
    Article Snippet: Notably, some of these cell types, particularly mesenchymal stem cells (MSCs), have already received clinical approval for use as living biodrugs, such as Prochymal (Osiris Therapeutics, Canada), Cartistem (Medipost Co Ltd, Korea), Stempeucel (Stempeutics Research), and Cellgram-AMI (FCB Pharmicell, South Korea) (Alliance for Regenerative Medicine; https:// allia ncerm. org/ avail able- produ cts/).

    Article Title: The inconclusive superiority debate of allogeneic versus autologous MSCs in treating patients with HFrEF: a systematic review and meta-analysis of RCTs
    Article Snippet: Notably, some of these cell types, particularly mesenchymal stem cells (MSCs), have already received clinical approval for use as living biodrugs, such as Prochymal (Osiris Therapeutics, Canada), Cartistem (Medipost Co Ltd, Korea), Stempeucel (Stempeutics Research), and Cellgram-AMI (FCB Pharmicell, South Korea) (Alliance for Regenerative Medicine; https://alliancerm.org/available-products/ ).



    Similar Products

    stempeucel  (Stempeutics)
    86
    Stempeutics stempeucel
    Stempeucel, supplied by Stempeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stempeucel/pmc13176351-22-2-3
    Average 86 stars, based on 1 article reviews
    stempeucel - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    stempeucel's allogeneic bm-mscs product  (Stempeutics)
    90
    Stempeutics stempeucel's allogeneic bm-mscs product
    MSC-based clinical trials for nerve injury and spinal cord injury (SCI).
    Stempeucel's Allogeneic Bm Mscs Product, supplied by Stempeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stempeucel/adult+allogenic+mscs/pmc11782851-243-20-5
    Average 90 stars, based on 1 article reviews
    stempeucel's allogeneic bm-mscs product - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    bone marrow-derived mesenchymal stem cells stempeucel  (Stempeutics)
    90
    Stempeutics bone marrow-derived mesenchymal stem cells stempeucel
    Mesenchymal stem cell (MSC) therapies have been approved by regulatory agencies worldwide.
    Bone Marrow Derived Mesenchymal Stem Cells Stempeucel, supplied by Stempeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stempeucel/human+mesenchymal+stem+cells++hmscs+/pmc11591657-39-6-11
    Average 90 stars, based on 1 article reviews
    bone marrow-derived mesenchymal stem cells stempeucel - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    MSC-based clinical trials for nerve injury and spinal cord injury (SCI).

    Journal: Regenerative Therapy

    Article Title: Beyond conventional therapies: MSCs in the battle against nerve injury

    doi: 10.1016/j.reth.2024.12.017

    Figure Lengend Snippet: MSC-based clinical trials for nerve injury and spinal cord injury (SCI).

    Article Snippet: An Indian company known as Stempeutics conducted a phase 4 clinical trial in September 2021, and the results indicated that Stempeucel's allogeneic BM-MSCs product was safe, effective, and had positive, long-lasting effects that not only reduced pain but aided in ulcer healing for severe limb ischemia triggered by Buerger's disease.

    Techniques: Clinical Proteomics, Transplantation Assay, Derivative Assay, Diffusion-based Assay, Imaging, Membrane, Cell Culture, Injection

    Mesenchymal stem cell (MSC) therapies have been approved by regulatory agencies worldwide.

    Journal: Bioengineering

    Article Title: Mesenchymal Stem Cells and Their Extracellular Vesicles Are a Promising Alternative to Antibiotics for Treating Sepsis

    doi: 10.3390/bioengineering11111160

    Figure Lengend Snippet: Mesenchymal stem cell (MSC) therapies have been approved by regulatory agencies worldwide.

    Article Snippet: Bone Marrow-Derived Mesenchymal Stem Cells , Stempeucel , Buerger’s disease , Stempeutics , India , 2020.

    Techniques: